1. Yan He, Miao Miao Sun, Guo Geng Zhang, Jing Yang, Kui Sheng Chen, Wen Wen Xu and Bin Li, Targeting PI3K/Akt signal transduction for cancer therapy, Signal Transduction and Targeted Therapy (2021) 6:425)2. https://www.fda.gov/media/161777/download.3. https://www.roche.com/media/releases/med-cor-2023-12-054. https://baijiahao.baidu.com/s?id=17758277531119851505. Discovery and characterization of RLY-2608, the first allosteric, mutant, and isoform-selective inhibitor of PI3Kα.6. https://aacrjournals.org/cancerres/article/83/5_Supplement/P4-08-02/717672/Abstract-P4-08-02-LOXO-783-A-potent-highly-mutant